Canaccord Genuity Maintains Buy on Omada Health, Lowers Price Target to $22
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and lowers the price target from $28 to $22.
Login to comment